SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

411 hedge funds and large institutions have $10.8B invested in Sarepta Therapeutics in 2024 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 145 increasing their positions, 122 reducing their positions, and 55 closing their positions.

Holders
411
Holders Change
+17
Holders Change %
+4.31%
% of All Funds
5.96%
Holding in Top 10
15
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+114.29%
% of All Funds
0.22%
New
75
Increased
145
Reduced
122
Closed
55
Calls
$649M
Puts
$198M
Net Calls
+$452M
Net Calls Change
+$159M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$318M
2
EC
2
EcoR1 Capital
California
$249M
3
PBA
3
Paradigm Biocapital Advisors
New York
$140M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$237M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$60.8M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$115M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$420M
3
Bank of America
3
Bank of America
North Carolina
$84.6M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$633M
5
DTC
5
Deep Track Capital
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.14B 8,795,754 -20,370 -0.2%
BlackRock
2
BlackRock
New York
$772M 5,960,370 -251,422 -4%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$633M 4,891,417 -454,368 -8%
Capital International Investors
4
Capital International Investors
California
$624M 4,817,517 +76,032 +2%
ACA
5
Avoro Capital Advisors
New York
$562M 4,344,444 – –
Wellington Management Group
6
Wellington Management Group
Massachusetts
$420M 3,245,798 -881,812 -21%
FCM
7
Farallon Capital Management
California
$318M 2,453,500 +1,243,427 +103%
State Street
8
State Street
Massachusetts
$275M 2,122,491 -276,587 -12%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$268M 2,067,037 -262,519 -11%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$250M 1,931,547 +11,805 +0.6%
EC
11
EcoR1 Capital
California
$249M 1,919,835 +1,086,928 +130%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$237M 1,828,602 +526,045 +40%
Citadel Advisors
13
Citadel Advisors
Florida
$197M 1,523,077 +180,347 +13%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$197M 1,520,370 +50,833 +3%
Deutsche Bank
15
Deutsche Bank
Germany
$189M 1,460,475 -14,487 -1%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$175M 1,348,570 -158,494 -11%
Pictet Asset Management
17
Pictet Asset Management
Switzerland
$163M 1,258,536 +166,934 +15%
PBA
18
Paradigm Biocapital Advisors
New York
$140M 1,078,346 +1,078,346 New
CC
19
Casdin Capital
New York
$138M 1,069,000 +62,500 +6%
Norges Bank
20
Norges Bank
Norway
$125M 968,798 +131,949 +16%
Morgan Stanley
21
Morgan Stanley
New York
$115M 888,433 -1,871,865 -68%
Millennium Management
22
Millennium Management
New York
$113M 874,147 +230,009 +36%
O
23
OrbiMed
New York
$90.3M 697,500 – –
Two Sigma Advisers
24
Two Sigma Advisers
New York
$85.6M 661,334 -44,800 -6%
Bank of America
25
Bank of America
North Carolina
$84.6M 653,465 -558,912 -46%
1
2 3 4 5